Events and Programs


Growing a Healthcare System
Patty Maysent ('90), CEO, UC San Diego Health
Recorded February 21, 2020

Drug Discovery in Neuroscience
Kevin Gorman (Ph.D. ’87, ’91), CEO, Neurocrine Biosciences
Recorded February 21, 2020
Fernanda Bravo, et al: “The Nature and Sources of Variability in Pediatric Surgical Case Duration”
Read MoreJennifer Kao: “Carted Territory: Evidence from Mapping Cancer Genome and R&D Decisions in the Pharmaceutical”
Read MoreVelibor Misic, et. al: “Adaptive and Robust Radiation Therapy Optimization for Lung Cancer”
Read MoreVelibor Misic, et al: “The Perils of Adapting to Dose Errors in Radiation Therapy”
Read MoreVelibor Misic, et. al: “Neighborhood Search Approaches to Non-Coplanar Beam Orientation Optimization for Total Marrow Irradiation Using IMRT”
Read MoreVelibor Misic: “Computational Enhancements to Fluence Map Optimization for Total Marrow Irradiation Using IMRT”
Read MoreVelibor Misic, et. al: “Machine Learning Prediction of Postoperative Emergency Department Hospital Readmission”
Read MoreAimee Drolet Rossi, Suzanne Shu, et. al: “Assessing Self-Control and Geosocial Networking App Behavior Among an Online Sample of Men Who Have Sex with Men
Read MoreSuzanne Shu, et. al: “Are Centers for Disease Control and Prevention Guidelines for Pre-Exposure Prophylaxis Specific Enough? Formulation of a Personalized HIV Risk Score for Pre-Exposure Prophylaxis Initiation”
Read MoreYounger-patient mortality rate nearly triples, 20 years of data indicate
A model outperformed simpler statistical approaches in predicting which patients would encounter trouble
Cost burdens affect half of U.S. households that rent, as housing shortage worsens
The anti-infection procedure rises for a time, when workers are watched, and then falls off
Patty Maysent ('90), CEO, UC San Diego Health
Recorded February 21, 2020
Kevin Gorman (Ph.D. ’87, ’91), CEO, Neurocrine Biosciences
Recorded February 21, 2020